Last Update 25 Apr 26
Fair value Decreased 0.10%ECL: Structural Pricing Power Will Support Execution Of CoolIT Data Center Acquisition
Analysts nudged the price target on Ecolab slightly lower to reflect a fair value adjustment of about $0.33, balancing more cautious margin and discount rate assumptions with Street research that highlights both recent target cuts and a string of upgrades and price target increases related to pricing power and the CoolIT acquisition.
Analyst Commentary
Street research on Ecolab has been active, with a mix of higher and lower price targets alongside several upgrades. Recent notes focus on pricing actions, the CoolIT acquisition and how much investors should pay for the stock given these factors.
Bullish Takeaways
- Bullish analysts highlight Ecolab's announced 10% to 14% price increases across products, services and geographies as a key support for margins and revenue quality, and see this pricing as a potentially lasting part of the company’s model rather than a temporary lever.
- Several research houses have raised price targets, including large upward moves such as the US$50 lift referenced in Morgan Stanley research and higher targets from firms like Mizuho, JPMorgan and others. This indicates that some on the Street are comfortable with a higher valuation anchor if execution stays on track.
- Upgrades to more positive ratings, including from firms like JPMorgan and Berenberg, point to confidence in Ecolab's execution on pricing, its ability to pass through inflation and its positioning as what one analyst called a net inflation beneficiary.
- Research covering the US$4.75b CoolIT deal frames the acquisition as an important part of the long term story. Bullish analysts focus on the potential for incremental growth avenues that can support their higher price targets.
Bearish Takeaways
- Bearish analysts have trimmed price targets, in some cases by US$15 to US$25, reflecting more conservative views on what investors should be willing to pay for the stock and signalling concern that prior expectations may have been too rich.
- Some research flags valuation as stretched relative to perceived risk, with the CoolIT acquisition described as carrying a hefty valuation. This raises questions about deal economics and execution risk for that capital deployment.
- Target cuts from several firms indicate caution around how quickly pricing actions, including the 10% to 14% increases, can translate into sustained earnings power, with a focus on whether customers fully absorb these moves without pressure on volumes or relationships.
- The split between upgrades and downgrades underscores that not all analysts agree on Ecolab’s risk reward trade off at current levels. More cautious voices are leaning on discount rate assumptions and margin uncertainty when setting lower fair value estimates.
What's in the News
- Ecolab is nearing a deal to buy CoolIT from KKR for US$4.5b to US$5b, according to multiple reports that describe the transaction as a large-scale addition to the portfolio (WSJ).
- Press coverage reiterates that Ecolab is close to acquiring CoolIT within a US$4.5b to US$5b value range, highlighting investor focus on deal size and integration plans (WSJ).
- Ecolab announced Ecolab Water Navigator IQ, an AI-enabled platform designed to give companies an enterprise-wide view of water performance, using site-level insights and predictive analytics to support water use decisions across more than 40 industries and 170 countries (company announcement, Earth Day).
- The company reported that from October 1, 2025 to December 31, 2025, it repurchased 1,500,000 shares for US$399.83m, bringing total buybacks under the program announced on February 26, 2010 to 59,088,331 shares for US$6,897.4m, or 21.94% of shares (company filing).
- Broader energy market news includes reports that the White House is preparing an E15 waiver for summer gasoline sales. This can influence input costs and operating conditions for industrial suppliers like Ecolab, depending on how fuel markets respond (Bloomberg).
Valuation Changes
- Fair Value was trimmed slightly from $319.29 to $318.95, reflecting a very small adjustment in the model output.
- The Discount Rate was nudged higher from 7.44% to 7.46%, implying a modestly higher required return for the equity.
- Revenue Growth was updated from 7.48% to 7.85%, indicating a slightly higher assumed top line growth rate in the model.
- The Net Profit Margin eased from 15.13% to 14.97%, pointing to a small reduction in assumed profitability on each $ of revenue.
- The Future P/E was kept broadly steady with a move from 36.31x to 36.30x, so the valuation multiple assumption is effectively unchanged.
Key Takeaways
- Ecolab's One Ecolab initiative focuses on market share gains and value pricing, aiming to improve revenue growth and net margins by delivering exceptional customer value.
- Strategic pricing adjustments, digital technology investments, and Life Sciences growth position Ecolab for improved operating income margins and long-term earnings potential.
- Softer demand, international tariffs, and local supplier costs may compress margins, despite strategic investments that could offer long-term growth.
Catalysts
About Ecolab- Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
- Ecolab is focusing on expanding its One Ecolab growth initiative, aiming to capitalize on market share gains and increased value pricing. This initiative is expected to drive revenue growth and improve net margins by delivering exceptional value to customers.
- Investments in digital technologies have led to improved productivity, resulting in a 190-basis-point increase in operating income margin. Continued investment in these technologies is anticipated to enhance earnings and operating margins further.
- The company has announced a 5% trade surcharge to offset the impact of tariffs, expecting it to bolster organic sales growth and support operating margins by the third quarter. Such strategic pricing adjustments can protect revenue and profitability from global trade fluctuations.
- Life Sciences is positioned for accelerated long-term growth, with mid-single-digit sales growth and significant share gains in its biopharma business. Investments in innovation and capacity expansion are anticipated to achieve operating income margins close to 30%, positively affecting long-term earnings potential.
- Ecolab digital experienced a 12% sales growth, primarily driven by subscription revenue, and the company aims to capitalize on this high-margin opportunity by expanding digital offerings. This is expected to significantly impact sales growth and operating income margins as these offerings scale.
Ecolab Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Ecolab's revenue will grow by 7.9% annually over the next 3 years.
- Analysts assume that profit margins will increase from 12.9% today to 15.0% in 3 years time.
- Analysts expect earnings to reach $3.0 billion (and earnings per share of $10.77) by about April 2029, up from $2.1 billion today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 36.3x on those 2029 earnings, down from 36.7x today. This future PE is greater than the current PE for the US Chemicals industry at 29.6x.
- Analysts expect the number of shares outstanding to decline by 0.54% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.46%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Softer demand in heavy industrial markets and expectations of continued softness, particularly as customer production rates in some industries have eased, could impact revenue growth.
- Rapid changes in international trade policies and global tariffs, particularly the 145% tariff on China, are increasing costs related to raw materials, packaging, and equipment, which could affect net margins.
- While strategic investments in growth engines like Life Sciences and Pest Intelligence may fuel long-term growth, they could have a near-term impact on operating income margins as these initiatives ramp up.
- The global onshoring trend has increased local supplier costs due to higher demand, which could compress margins if not offset by cost efficiencies and surcharges.
- Price surcharges like the newly announced 5% trade surcharge in the U.S. could face resistance from customers, potentially impacting sales volumes and complicating the company's pricing strategy.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $318.95 for Ecolab based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $352.0, and the most bearish reporting a price target of just $270.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $20.2 billion, earnings will come to $3.0 billion, and it would be trading on a PE ratio of 36.3x, assuming you use a discount rate of 7.5%.
- Given the current share price of $269.49, the analyst price target of $318.95 is 15.5% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Ecolab?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.